All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 166 of 206 pages ‹ First < 164 165 166 167 168 > Last ›
HSL2104
Isaacs D, Fitzgerald D.
Seven alternatives to evidence based medicine.
BMJ 1999 Dec 18-25;319:(7225):1618
http://bmj.bmjjournals.com/cgi/content/full/319/7225/1618
HSL20120
Turner J
A new Rx for drugs
The Toronto Star 1999 Dec 10
HSL20010
Mackinven M
Sales reps losing ground with GPs
New Zealand Doctor News 1999 Dec 9
HSL19870
Moynihan R
A Case of Hype v Hope
The Bulletin 1999 Dec 725-32
http://www.faqs.org/abstracts/News-opinion-and-commentary/A-case-of-hype-v-hope-Power-plays-Howard-back-flip-leaves-Lees-unfazed.html
HSL7948
Business outlook 2000: here we come!
Drug Topics 1999 Dec 6;143:76-78, 80, 82, 87-88, 90, 93-9
HSL7905
Marshall G.
Common market
Chemist and Druggist 1999 Dec 4;252:
HSL6869
Lovdahl U, Riska A, Riska E.
Gender display in Scandinavian and American advertising for antidepressants.
Scand J Public Health 1999 Dec;27:(4):306-10
HSL6919
Lexchin J.
Re: the promotion of Rocmaline (arginine, malic acid) in French-speaking Africa
1999 Dec;
HSL7892
Anon .
R&D success boosts brand name pharmaceuticals
HealthCare Distributors 1999 Dec;51:12-14, 16, 18-20
HSL7929
Hollenbeak CS.
The effect of generic competition on prescription to over-the-counter switching.
Pharmacoeconomics 1999 Dec;16:(6):661-8
HSL8105
Jensen MJ.
Development of a searchable Internet database to provide medical information from a pharmaceutical company to health care professionals
ASHP Midyear Clinical Meeting 1999 Dec;34:
HSL8107
Mehl B.
Pharmaceutical trends: overview of factors responsible for increasing pharmaceutical expenditures
ASHP Midyear Clinical Meeting 1999 Dec;34:
HSL8108
Stein GC.
Current federal regulatory trends
ASHP Midyear Clinical Meeting 1999 Dec;34:
HSL12016
Daughton CG, Ternes TA.
Pharmaceuticals and personal care products in the environment: agents of subtle change?
Environ Health Perspect 1999 Dec;107:
http://www.pubmedcentral.nih.gov.ezlibproxy.unisa.edu.au/articlerender.fcgi?tool=pmcentrez&artid=1566206
HSL6918
Pirisi A.
Patient-directed drug advertising puts pressure on US doctors
Lancet 1999 Nov 27;354:1887
*news story/United Kingdom/United States/
HSL20008
Jackson A
Getting drug reps under control
Australian Doctor 1999 Nov 2674
HSL19548
Cauchon D
Americans Pay More for Medicines
USA Today 1999 Nov 20
http://www.usatoday.com/life/health/drugs/lhdru066.htm
HSL2151
Wynia MK, Latham SR, Kao AC, Berg JW, Emanuel LL.
Medical professionalism in society.
N Engl J Med 1999 Nov 18;341:(21):1612-6
http://content.nejm.org/cgi/content/extract/341/21/1612
HSL6877
Price VH.
Authors' conflicts of interest: a disclosure and editors' reply.
N Engl J Med 1999 Nov 18;341:(21):1618-9
HSL7928
Conlan MF.
Bill goes after Flo as battle for Medicare Rx benefit heats up
Drug Topics 1999 Nov 15;143:71
HSL20146
Mant A
On the (mis)information superhighway
Medical Observer 1999 Nov 12
HSL6859
Johansen HK, Gotzsche PC.
Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis.
JAMA 1999 Nov 10;282:(18):1752-9
http://jama.ama-assn.org/cgi/content/full/282/18/1752
HSL6917
Rennie D.
Fair conduct and fair reporting of clinical trials.
JAMA 1999 Nov 10;282:(18):1766-8
http://jama.ama-assn.org/cgi/content/full/282/18/1766
HSL20176
MacKinven M
DTC advertising isn't a black and white issue
Australian Doctor 1999 Nov 1019
HSL6916
Pakenham-Walsh N, Eddleston M, Kaur M.
Developing world needs access to low cost pharmaceutical information from reliable sources.
BMJ 1999 Nov 6;319:(7219):1265
http://bmj.com/cgi/content/full/319/7219/1265, http://bmj.com/cgi/reprint/319/7219/1265.pdf
HSL5318
Bell RA, Kravitz RL, Wilkes MS.
Direct-to-consumer prescription drug advertising and the public.
J Gen Intern Med 1999 Nov 01;14:(11):651-7
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1525-1497.1999.01049.x
HSL8098
With 100 days to Y2K, some health care settings remained vulnerable
American Journal of Health System Pharmacy 1999 Nov 1;56:2181
HSL1841
Jackson C, Mcguire T, Dommers E, Nyst P.
A GP prescribing educational intervention involving a medication panel.
Aust Fam Physician 1999 Nov;28:(11):1191-5
HSL1842
Slawson DC, Shaughnessy AF.
Teaching information mastery: creating informed consumers of medical information.
J Am Board Fam Pract 1999 Nov-Dec;12:(6):444-9
HSL6860
Kjaergard LL, Nikolova D, Gluud C.
Randomized clinical trials in hepatology: predictors of quality.
Hepatology 1999 Nov;30:(5):1134-8
http://www3.interscience.wiley.com/cgi-bin/abstract/106596467/ABSTRACT?CRETRY=1&SRETRY=0
HSL6912
Charlish P.
DTC advertising encourages consumers to talk about drugs
Scrip Magazine 1999 Nov9-10
www.pjbpubs.co.uk/scrip/scrhome.html
HSL6913
Law J.
Preparing to advertising directly to the European consumer
Scrip Magazine 1999 Nov;(84):6-7
www.pjbpubs.co.uk/scrip/scrhome.html
HSL6915
Redelmeier DA.
Drug dependence in a journal club.
ACP J Club 1999 Nov-Dec;131:(3):A13-4
HSL7731
Allen J.
Surgical internet at a glance: healthcentral and drKoop.
Am J Surg. 1999 Nov;178:(5):359
http://linkinghub.elsevier.com/retrieve/pii/S0002-9610(99)00214-7
HSL7922
Hallahan M, Madell R.
Rx branding: brand new culture
Pharmaceutical Executive 1999 Nov;19:98-100, 102, 104
HSL7923
Wechsler J.
DTC dilemma
Pharmaceutical Executive 1999 Nov;19:22, 24, 26-27
HSL7924
Pal S.
Generic industry market review
US Pharmacist 1999 Nov;19:(24):9, 14-15, 22-23, 30, 34
HSL7946
Beavers N.
Generic industry abuzz over Medicare, exclusivity proposals
Drug Topics 1999 Nov;143:
HSL6841
Bosch X.
Spain investigates "bribery" of doctors.
Lancet 1999 Oct 30;354:(9189):1537
HSL6876
Phillips SG, Carey LA.
Whose article is it anyway?
Lancet 1999 Oct 30;354:(9189):1563
HSL18023
Ferriman A.
Selling drugs to consumers
BMJ 1999 Oct 30;319:(7218):1208
http://www.bmj.com/cgi/content/full/319/7218/1208?view=long&pmid=10541537
HSL20123
Reguly E
Battle brews over Canadian drug ads
The Globe and Mail 1999 Oct 30B2
HSL6839
Armstrong K, Schwartz JS, Asch DA.
Direct sale of sildenafil (Viagra) to consumers over the Internet.
N Engl J Med 1999 Oct 28;341:(18):1389-92
http://content.nejm.org/cgi/content/extract/341/18/1389
HSL6852
Friedberg M, Saffran B, Stinson TJ, Nelson W, Bennett CL.
Evaluation of conflict of interest in economic analyses of new drugs used in oncology.
JAMA 1999 Oct 20;282:(15):1453-7
http://jama.ama-assn.org/cgi/content/full/282/15/1453
HSL6911
Krimsky S.
Conflict of interest and cost-effectiveness analysis.
JAMA 1999 Oct 20;282:(15):1474-5
http://jama.ama-assn.org/cgi/content/full/282/15/1474
HSL7904
van den Hoogen H, Hooijman G, Meulepas M.
Bottom up approach of local pharmacotherapeutic consultations involving pharmacists and general practitioners
Pharmaceutisch Weekblad 1999 Oct 15;134:1400-1404
HSL20014
Jacobs A
Reasons for not seeing drug representatives: But doctors do see them: 'freebies' seem disproportionately important
BMJ 1999 Oct 9;319:(7215):1002
http://www.ncbi.nlm.nih.gov/pubmed/10576839
HSL6909
Mansfield P.
Debate: drug advertising
Australian Doctor 1999 Oct 864
HSL6910
McLean DL.
Debate: drug advertising
Australian Doctor 1999 Oct 864
HSL20170
McLean DL
Debate: drug advertising: Yes
Australian Doctor 1999 Oct 8
HSL20171
Mansfield P
Debate: drug advertising: No
Australian Doctor 1999 Oct 864
HSL6906
Alper PR.
Direct-to-consumer advertising: education or anathema?
JAMA 1999 Oct 6;282:(13):1226-7
http://jama.ama-assn.org/cgi/content/full/282/13/1226
HSL6907
Holmer AF.
Direct-to-consumer advertising: Education or anathema? [reply]
JAMA 1999 Oct 6;282:(13):1227-1228
HSL6908
Rosner F, Kark P, Packer S, Bennett A, Berger J.
Direct-to-consumer advertising: education or anathema?
JAMA 1999 Oct 6;282:(13):1227
HSL8102
New community pharmacy foundation to benefit from lawsuits against drug companies
American Journal of Health System Pharmacy 1999 Oct 1;56:1912, 1915
HSL1032
Lexchin J.
Don't bite the hand that feeds you.
West J Med 1999 Oct;171:(4):238-9
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=10578675
HSL2263
Perri M 3rd, Shinde S, Banavali R.
The past, present, and future of direct-to-consumer prescription drug advertising.
Clin Ther 2001 nov;21:(10):1798-811
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VRS-3YF46RW-J&_coverDate=10%2F31%2F1999&_alid=305967821&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=6242&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=18edbefe7a0a00f2fd03cf0fb73399c6
HSL6853
Glassman PA, Hunter-Hayes J, Nakamura T.
Pharmaceutical advertising revenue and physician organizations: how much is too much?
West J Med 1999 Oct;171:(4):234-8
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=10578674
HSL7921
Bowles R, Howell P, Ott T, Heller S.
Medicare Rx benefits: implications for the pharmaceutical industry
Pharmaceutical Executive 1999 Oct;19:62, 64, 66, 68, 70
HSL7951
Settlement funds: distribution decided in price-fixing case
America's Pharmacist 1999 Oct;121:20-21
HSL7964
Wechsler J.
Controversy over prescription drug advertising stimulates policy changes
Formulary 1999 Oct;34:878-879
HSL7966
Schwartz RM.
TV ad campaign fights Clinton Rx plan
American Druggist 1999 Oct;216:15
HSL2031
Drug-company decision to end cancer trial.
Lancet 1999 Sep 25;354:(9184):1045
http://linkinghub.elsevier.com/retrieve/pii/S0140673699003207
HSL20175
Parnell K
Barrage of wrong information
Australian Doctor 1999 Sep 2427
HSL6905
Rhame FS.
Implications of "market baskets," a pharmaceutical marketing practice.
JAMA 1999 Sep 22-29;282:(12):1134
http://jama.ama-assn.org/cgi/content/full/282/12/1134
HSL6849
Elston MJ.
Following the rules in marketing.
CMAJ 1999 Sep 21;161:(6):685
http://www.cma.ca/cmaj/vol-161/issue-6/letters-6.htm
HSL8100
FDA finalizes guidance on DTC broadcast ads
American Journal of Health System Pharmacy 1999 Sep 15;56:1815
HSL8101
Congress explores limits on Internet pharmacy
American Journal of Health System Pharmacy 1999 Sep 15;56:1812
HSL7932
Newton P.
Promotion vs regulation
Chemist and Druggist 1999 Sep 11;27
HSL19549
Prescription Drug Pricing in the United States: Drug Companies Profit at the Expense of Older Americans
U.S. House of Representatives. 1999 Sep 11
HSL19938
Bisset K, Parnell K
Ad comments off target
Australian Medicine 1999 Sep 6
HSL19939
Hui L, Hayman M
S4 advertising no help
Australian Medicine 1999 Sep 66
HSL3687
Dyer C.
Incontinence campaign tests limits of advertising rules.
BMJ 1999 Sep 4;319:(7210):591
http://bmj.bmjjournals.com/cgi/content/full/319/7210/591
HSL1895
The fine line between education and marketing..
Proj Inf Perspect 1999 Sep 01;(28):1-3
HSL200
Vandenbroucke JP, Helmerhorst FM, Rosendaal FR.
Competing interests and controversy about third generation oral contraceptives: BMJ readers should know whose words they read.
BMJ 1999 Sep;319:(7213):795-6
http://bmj.bmjjournals.com/cgi/content/full/320/7231/381/a
HSL7729
Mani MK.
A Faustian bargain.
Natl Med J India 1999 Sep-Oct;12:(5):244-5
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10613011&dopt=Abstract
HSL7926
Koberstein W.
Media Mix: Rx marketers blend consumer & medical campaigns
Pharmaceutical-Executive 1999 Sep;19:46-47
HSL7927
Koberstein W.
Media Mix masters: PE's annual agency roundtable
Pharmaceutical Executive 1999 Sep;19:50-84
HSL7933
Morris L.
DTC & Rx costs: circumstantial case
Pharmaceutical Executive 1999 Sep;19:20
HSL7953
Lyftingsmo S.
Survey on labeling 1999
International Pharmacy Journal 1999 Sep-Oct;13:127
HSL7978
Colchamiro R.
Generic drugs: patent wars rage on
American Druggist 1999 Sep;216:33-34, 36-38, 40, 42
HSL6855
Hafeez A, Mirza Z.
Responses from pharmaceutical companies to doctors' requests for more drug information in Pakistan: postal survey.
BMJ 1999 Aug 28;319:(7209):547
http://www.bmj.com/cgi/content/full/319/7209/547
HSL2096
Bucher HC, Guyatt GH, Cook DJ, Holbrook A, McAlister FA.
Users' guides to the medical literature: XIX .Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. Evidence-Based Medicine Working Group.
JAMA 1999 Aug 25;282:(8):771-8
http://jama.ama-assn.org/cgi/content/full/282/8/771
HSL6904
Glaser T.
Yes . . . but what solutions?
BMJ 1999 Aug 23;319:(7208):525
http://bmj.com/cgi/eletters/319/7208/525/a#4335
HSL6903
Dunea G.
Fancy drugs for worried folks.
BMJ 1999 Aug 21;319:(7208):525A
HSL6902
Vermeulen L.
Clarification and amplification
BMJ 1999 Aug 20;319:(7208):525
http://bmj.com/cgi/eletters/319/7208/525/a#4335
HSL6882
Ruffmann R.
Funding of clinical research.
Lancet 1999 Aug 14;354:(9178):602
HSL2013
Silverstein K.
Millions for Viagra, Pennies for the Poor
The Toronto Star 1999 Aug 13
HSL16738
Wolfe S
Promotion of Off-Label Uses of Drugs
USA Today 1999 Aug 9
HSL6901
Cottle M.
Selling shyness: how doctors and drug companies created the “social phobia” epidemic
New Republic 1999 Aug 2
HSL8104
Sellers JA.
Medicare drug benefit.
Am J Health Syst Pharm 1999 Aug 1;56:(15):1503
http://www.ajhp.org/cgi/reprint/56/15/1503
HSL6850
Ferguson RP, Rhim E, Belizaire W, Egede L, Carter K, Lansdale T.
Encounters with pharmaceutical sales representatives among practicing internists.
Am J Med 1999 Aug;107:(2):149-52
http://linkinghub.elsevier.com/retrieve/pii/S0002934399001928
HSL7958
Schwartz H.
Unlikely support
Pharmaceutical Executive 1999 Aug;19:26, 28
HSL7960
Smith D.
Does your DTC message pass the consumer litmus test?
Pharmaceutical-Executive 1999 Aug;19:9
HSL8091
Rankin K.
Generic manufacturers look to Washington for change
Pharmacy Times 1999 Aug;66:79-80, 82
HSL20269
Chren M-M
Interactions between physicians and drug company representatives
Am J Med 1999 Aug;107:(2):182-3
http://www.ncbi.nlm.nih.gov/pubmed/10460053
HSL14669
Riggert E.
Drug firms' 'gifts' to GPs
The Advertiser 1999 Jul 26
HSL19940
Hansen K
Are medical publications selling out?
Australian Medicine 1999 July 1910-11
HSL6854
Griffith D.
Reasons for not seeing drug representatives.
BMJ 1999 Jul 10;319:(7202):69-70
http://www.bmj.com/cgi/content/full/319/7202/69
HSL6862
Larkin M.
Whose article is it anyway?
Lancet 1999 Jul 10;354:(9173):136
Page 166 of 206 pages ‹ First < 164 165 166 167 168 > Last ›
